Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05026632
PHASE1/PHASE2

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Sponsor: Nacuity Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.

Official title: Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2022-01-27

Completion Date

2026-09-03

Last Updated

2026-10-09

Healthy Volunteers

No

Conditions

Interventions

DRUG

NPI-002 Intravitreal Implant

Implant inserted during vitrectomy.

Locations (1)

Royal Adelaide Hospital

Adelaide, Australia